<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; prevention</title>
	<atom:link href="http://www.tapanray.in/tag/prevention/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Providing Unique Patient Experience &#8211; A New Brand Differentiator</title>
		<link>http://www.tapanray.in/providing-unique-patient-experience-a-new-brand-differentiator/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=providing-unique-patient-experience-a-new-brand-differentiator</link>
		<comments>http://www.tapanray.in/providing-unique-patient-experience-a-new-brand-differentiator/#comments</comments>
		<pubDate>Sun, 04 Mar 2018 23:50:22 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[AR]]></category>
		<category><![CDATA[Augmented]]></category>
		<category><![CDATA[behavior]]></category>
		<category><![CDATA[brand]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[consumer]]></category>
		<category><![CDATA[differentiator]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[experience]]></category>
		<category><![CDATA[Flatiron]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Internet of Things]]></category>
		<category><![CDATA[IoT]]></category>
		<category><![CDATA[marketers]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[outcomes]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[prevention]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Roche]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[unique]]></category>
		<category><![CDATA[Virtual reality]]></category>
		<category><![CDATA[VR]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8887</guid>
		<description><![CDATA[“Pharma industry, including the patients in India are so different from other countries. Thus, any strategic shift from conventional pharma brand marketing approach &#8211; going beyond doctors, won’t be necessary.” The above mindset is interesting and may well hold good &#8230; <a href="http://www.tapanray.in/providing-unique-patient-experience-a-new-brand-differentiator/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/providing-unique-patient-experience-a-new-brand-differentiator/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Immunization Still Remains A Low-Budget Neglected Area In India</title>
		<link>http://www.tapanray.in/immunization-still-remains-a-low-budget-neglected-area-in-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=immunization-still-remains-a-low-budget-neglected-area-in-india</link>
		<comments>http://www.tapanray.in/immunization-still-remains-a-low-budget-neglected-area-in-india/#comments</comments>
		<pubDate>Sun, 18 Dec 2016 22:46:33 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Budget]]></category>
		<category><![CDATA[burden]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[GAVI]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[immunization]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[low]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[prevention]]></category>
		<category><![CDATA[Priority]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[program]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[spectrum]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[vaccines]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8012</guid>
		<description><![CDATA[Although India is a leading producer and exporter of vaccines, the country has the greatest number of deaths among children under 5, and the majority are from vaccine-preventable diseases. Less than 44 percent of India&#8217;s young children receive the full &#8230; <a href="http://www.tapanray.in/immunization-still-remains-a-low-budget-neglected-area-in-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/immunization-still-remains-a-low-budget-neglected-area-in-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>“Meeting Unmet Needs of Patients”: A New Direction</title>
		<link>http://www.tapanray.in/meeting-unmet-needs-of-patients-a-new-direction/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=meeting-unmet-needs-of-patients-a-new-direction</link>
		<comments>http://www.tapanray.in/meeting-unmet-needs-of-patients-a-new-direction/#comments</comments>
		<pubDate>Mon, 27 Jan 2014 00:00:00 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[banal]]></category>
		<category><![CDATA[direction]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[evergreen]]></category>
		<category><![CDATA[genetics]]></category>
		<category><![CDATA[genome]]></category>
		<category><![CDATA[genomics]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[Meeting]]></category>
		<category><![CDATA[needs]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[personalized]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[prevention]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[sequencing]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tufts]]></category>
		<category><![CDATA[unmet]]></category>
		<category><![CDATA[warfarin]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=4874</guid>
		<description><![CDATA[The much-hyped phrase of the global pharma majors &#8211; ‘meeting unmet needs of patients’, is very often used to create an aura around newer patented drugs of all kinds, from original to banal, including evergreen varieties such as: Evergreen Drug/Brand &#8230; <a href="http://www.tapanray.in/meeting-unmet-needs-of-patients-a-new-direction/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/meeting-unmet-needs-of-patients-a-new-direction/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vaccines Development: Is it Just a Business Based on Fear?</title>
		<link>http://www.tapanray.in/vaccines-development-is-it-just-a-business-based-on-fear/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=vaccines-development-is-it-just-a-business-based-on-fear</link>
		<comments>http://www.tapanray.in/vaccines-development-is-it-just-a-business-based-on-fear/#comments</comments>
		<pubDate>Mon, 26 Aug 2013 00:00:26 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Based]]></category>
		<category><![CDATA[Bill]]></category>
		<category><![CDATA[Buchwald]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Costs]]></category>
		<category><![CDATA[diphtheria]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[enough]]></category>
		<category><![CDATA[Expenses]]></category>
		<category><![CDATA[fear]]></category>
		<category><![CDATA[First]]></category>
		<category><![CDATA[Gates]]></category>
		<category><![CDATA[GAVI]]></category>
		<category><![CDATA[Gerhard]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[growth]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[JV]]></category>
		<category><![CDATA[local]]></category>
		<category><![CDATA[malaria]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[MSD]]></category>
		<category><![CDATA[NCD]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[NIH]]></category>
		<category><![CDATA[Not]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Partnership]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[pox]]></category>
		<category><![CDATA[prevention]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[research]]></category>
		<category><![CDATA[Sanofi]]></category>
		<category><![CDATA[small]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[TB]]></category>
		<category><![CDATA[threat]]></category>
		<category><![CDATA[Tuberculosis]]></category>
		<category><![CDATA[vaccination]]></category>
		<category><![CDATA[vaccines]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=3486</guid>
		<description><![CDATA[‘Vaccination – A Business based on fear’, is the title of a book written by Dr. Gerhard Buchwald M.D, a German medical doctor and a vaccination critic. This book talks about: “The damage and the deaths caused by vaccination are written &#8230; <a href="http://www.tapanray.in/vaccines-development-is-it-just-a-business-based-on-fear/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/vaccines-development-is-it-just-a-business-based-on-fear/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Encourage vaccine research and improve its access to demonstrate ‘prevention is better than cure’</title>
		<link>http://www.tapanray.in/encourage-vaccine-research-and-improve-its-access-to-demonstrate-prevention-is-better-than-cure/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=encourage-vaccine-research-and-improve-its-access-to-demonstrate-prevention-is-better-than-cure</link>
		<comments>http://www.tapanray.in/encourage-vaccine-research-and-improve-its-access-to-demonstrate-prevention-is-better-than-cure/#comments</comments>
		<pubDate>Mon, 16 Jan 2012 00:00:10 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[better]]></category>
		<category><![CDATA[cure]]></category>
		<category><![CDATA[demonstrate]]></category>
		<category><![CDATA[Encourage]]></category>
		<category><![CDATA[improve]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[its]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[prevention]]></category>
		<category><![CDATA[Preventive]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[research]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[than]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[Vaccine]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=146</guid>
		<description><![CDATA[Vaccines are one of the most successful and cost-effective public health interventions, which help preventing over 2 million deaths every year. The World Health Organization (WHO) defines vaccines as: “A vaccine is any preparation intended to produce immunity to a &#8230; <a href="http://www.tapanray.in/encourage-vaccine-research-and-improve-its-access-to-demonstrate-prevention-is-better-than-cure/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/encourage-vaccine-research-and-improve-its-access-to-demonstrate-prevention-is-better-than-cure/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>National Non-Communicable Disease (NCD) prevention program of the government needs a new thrust to contain the burden of disease in India.</title>
		<link>http://www.tapanray.in/national-non-communicable-disease-ncd-prevention-program-of-the-government-needs-a-new-thrust-to-contain-the-burden-of-disease-in-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=national-non-communicable-disease-ncd-prevention-program-of-the-government-needs-a-new-thrust-to-contain-the-burden-of-disease-in-india</link>
		<comments>http://www.tapanray.in/national-non-communicable-disease-ncd-prevention-program-of-the-government-needs-a-new-thrust-to-contain-the-burden-of-disease-in-india/#comments</comments>
		<pubDate>Mon, 05 Apr 2010 00:30:06 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[burden]]></category>
		<category><![CDATA[Communicable]]></category>
		<category><![CDATA[contain]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[National]]></category>
		<category><![CDATA[NCD]]></category>
		<category><![CDATA[needs]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[Non]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[prevention]]></category>
		<category><![CDATA[program]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[thrust]]></category>
		<category><![CDATA[to]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=445</guid>
		<description><![CDATA[The disease pattern in India is showing a perceptible shift from the age old ‘Infectious Diseases’ to ‘Non-infectious Chronic Illnesses’. As reported by IMS, incidence of chronic ailments in India has increased from 23 percent in 2005 to 26 percent &#8230; <a href="http://www.tapanray.in/national-non-communicable-disease-ncd-prevention-program-of-the-government-needs-a-new-thrust-to-contain-the-burden-of-disease-in-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/national-non-communicable-disease-ncd-prevention-program-of-the-government-needs-a-new-thrust-to-contain-the-burden-of-disease-in-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>‘Prevention is better than cure’: Such a healthcare policy focus could effectively reduce the disease burden in India</title>
		<link>http://www.tapanray.in/prevention-is-better-than-cure-such-a-healthcare-policy-focus-could-effectively-reduce-the-disease-burden-in-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=prevention-is-better-than-cure-such-a-healthcare-policy-focus-could-effectively-reduce-the-disease-burden-in-india</link>
		<comments>http://www.tapanray.in/prevention-is-better-than-cure-such-a-healthcare-policy-focus-could-effectively-reduce-the-disease-burden-in-india/#comments</comments>
		<pubDate>Mon, 17 Aug 2009 00:00:46 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[better]]></category>
		<category><![CDATA[burden]]></category>
		<category><![CDATA[could]]></category>
		<category><![CDATA[cure]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[effectively]]></category>
		<category><![CDATA[focus]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[prevention]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reduce]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[than]]></category>
		<category><![CDATA[the]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=806</guid>
		<description><![CDATA[First National Health Policy was passed by the Parliament of India in 1983 and was last updated in 2002. How much of the policy intent has seen the light of the day is anybody’s guess. Healthcare issues are not being &#8230; <a href="http://www.tapanray.in/prevention-is-better-than-cure-such-a-healthcare-policy-focus-could-effectively-reduce-the-disease-burden-in-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/prevention-is-better-than-cure-such-a-healthcare-policy-focus-could-effectively-reduce-the-disease-burden-in-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
